A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia

Pediatr Blood Cancer. 2019 Aug;66(8):e27821. doi: 10.1002/pbc.27821. Epub 2019 May 21.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinin / genetics*
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Infant
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Prognosis

Substances

  • ACTN2 protein, human
  • KMT2A protein, human
  • Oncogene Proteins, Fusion
  • Actinin
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase